Investor Relations

Corporate Profile

VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health for US, European and other world markets. For more information about the company, please visit www.vivus.com.